Skip to main content

Breast Cancer Learning Library

Sally Fang, MSN, RN, FNP-BC
Videos
10/01/2026
Sally Fang, MSN, RN, FNP-BC
Sally Fang, MSN, RN, FNP-BC, an advanced practice provider specializing in breast medical oncology at the University of California, San Francisco, discusses the increasingly complex treatment landscape for breast cancer and the evolving...
Sally Fang, MSN, RN, FNP-BC, an advanced practice provider specializing in breast medical oncology at the University of California, San Francisco, discusses the increasingly complex treatment landscape for breast cancer and the evolving...
Sally Fang, MSN, RN, FNP-BC, an...
10/01/2026
Oncology Learning Network APP Institute
Videos
05/29/2026
Katie Newlin, RN, MSN, AGPCNP-BC; Sanita Burgic, MSN, APRN, AGNP-C; Ashley Martinez, DNP, CBCN; Amanda Brink, DNP
05/29/2026
Oncology Learning Network APP Institute
Videos
05/29/2026
Amanda Brink, DNP; Sanita Burgic, MSN, APRN, AGNP-C; Ashley Martinez, DNP, CBCN; Katie Newlin, RN, MSN, AGPCNP-BC
05/29/2026
Oncology Learning Network APP Institute
Videos
05/29/2026
Sanita Burgic, MSN, APRN, AGNP-C; Ashley Martinez, DNP, CBCN; Katie Newlin, RN, MSN, AGPCNP-BC; Amanda Brink, DNP
05/29/2026
Oncology Learning Network APP Institute
Videos
05/29/2026
Ashley Martinez, DNP, CBCN; Sanita Burgic, MSN, APRN, AGNP-C; Katie Newlin, RN, MSN, AGPCNP-BC; Amanda Brink, DNP
05/29/2026
Oncology Learning Network APP Institute
Videos
05/29/2026
Katie Newlin, RN, MSN, AGPCNP-BC; Sanita Burgic, MSN, APRN, AGNP-C; Ashley Martinez, DNP, CBCN; Amanda Brink, DNP
05/29/2026
Oncology Learning Network APP Institute
Danielle Roman, PharmD, BCOP
Conference Coverage
12/11/2025
Danielle Roman, PharmD
Danielle Roman, PharmD, highlighted evolving treatment strategies for hormone receptor–positive, HER2-positive metastatic breast cancer, emphasizing the integration of HER2-targeted therapies, endocrine therapy, and emerging CDK4/6 inhibitors...
Danielle Roman, PharmD, highlighted evolving treatment strategies for hormone receptor–positive, HER2-positive metastatic breast cancer, emphasizing the integration of HER2-targeted therapies, endocrine therapy, and emerging CDK4/6 inhibitors...
Danielle Roman, PharmD,...
12/11/2025
Oncology Learning Network APP Institute
Videos
10/09/2025
Tiffany A. Traina, MD
In this introduction, Dr Tiffany Traina sets the stage for the session by outlining the current standard of care for programmed cell death protein 1 positive (PD-L1+) mTNBC.
In this introduction, Dr Tiffany Traina sets the stage for the session by outlining the current standard of care for programmed cell death protein 1 positive (PD-L1+) mTNBC.
In this introduction, Dr Tiffany...
10/09/2025
Oncology Learning Network APP Institute
Research Review
04/10/2025
Janelle Bradley
Epigenetic analysis in postmenopausal women with early-stage breast cancer reveals distinct biological pathways—axonal guidance and synaptogenesis—underlying objective and subjective cognitive function, suggesting separate mechanisms driving...
Epigenetic analysis in postmenopausal women with early-stage breast cancer reveals distinct biological pathways—axonal guidance and synaptogenesis—underlying objective and subjective cognitive function, suggesting separate mechanisms driving...
Epigenetic analysis in...
04/10/2025
Oncology Learning Network APP Institute
Research Review
11/20/2024
Allison Casey
According to the preplanned overall survival interim analysis from the phase 3 monarchE trial, abemaciclib plus endocrine therapy continues to show benefit for patients with HR-positive, HER2-negative high-risk early breast cancer.
According to the preplanned overall survival interim analysis from the phase 3 monarchE trial, abemaciclib plus endocrine therapy continues to show benefit for patients with HR-positive, HER2-negative high-risk early breast cancer.
According to the preplanned...
11/20/2024
Oncology Learning Network APP Institute
Research Review
04/26/2024

Allison Casey

Allison Casey
According to a study presented at the 2024 ONS Annual Congress, multiple alterations in gut microbial composition and diversity were associated with GI symptoms and breast cancer status.
According to a study presented at the 2024 ONS Annual Congress, multiple alterations in gut microbial composition and diversity were associated with GI symptoms and breast cancer status.
According to a study presented...
04/26/2024
Oncology Learning Network APP Institute